Responses
Regular and young investigator award abstracts
Clinical trials in progress
367 A phase 1/1b dose-escalation study of intravenously administered SB 11285 alone and in combination with atezolizumab in patients with advanced solid tumors
Compose a Response to This Article
Other responses
No responses have been published for this article.